• SENSEX 76,909.68
    -325.78 (--0.42%)
  • BANKNIFTY 57,262.40
    -235.40 (--0.41%)
  • Aster DM Quality
    766.10 519.80(%)
  • Dhoot Transmission
    1,436.85 1,306.25(%)
  • Oberoi Realty
    1,831.50 1,390.15(%)
  • Abbott India
    26,302.50 25,164.00(%)
  • Pfizer
    4,965.00 5,878.55(%)
  • Cupid
    291.00 298.95(%)
  • Cyient
    902.75 1,282.40(%)
  • HDFC Bank
    715.05 722.00(%)
  • Netweb Technol.
    5,024.00 2,037.65(%)
  • Himadri Special
    702.00 420.00(%)
  • SBI
    1,041.30 798.60(%)
  • Reliance Industries
    1,304.00 1,250.55(%)
  • Bharti Airtel
    1,921.35 1,745.00(%)
  • Kaynes Tech
    3,825.00 7,705.00(%)
  • Alkem Lab
    5,369.15 5,085.00(%)
  • Molbio Diagnosti
    1,013.65 925.80(%)
  • ICICI Bank
    1,391.10 1,187.55(%)
  • Vedant Fashions
    545.15 794.55(%)
  • Triveni Turbine
    561.35 428.50(%)
  • Power Fin.Corpn.
    376.50 486.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Strides Pharma Science Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16996.0
  • ISIN : INE939A01011
949.10 -38 (-3.85%)
  • As on 19 Aug 2026 (EOD)

  • Today’s Low

    944.10

  • Today’s High

    984.80

  • Open

    984.80

  • Perv Close

    987.10

  • 52W Low

    768.65

  • 52W High

    1,231.00

Key Indicators

  • P/E(TTM)

    48.39

  • Mar.Cap (₹Cr.)

    8,748.11

  • Div & Yield %

    0.53

  • Book Value(₹)

    356.24

  • Debt-Equity Ratio

    -3.85

  • AGM Date

    18-Aug-2026

  • EPS

    19.54

  • P/E Ratio

    48.39

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    8,748.11

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    92.17

  • BV (₹)

    356.20

  • Sales( ₹ in Cr.)

    2,180.14

  • NP (in Cr.)

    73.56

  • NP Var(%)

    -97.0

  • Div%

    50.0

  • CPS (₹)

    17.90

  • EPS (₹)

    8.00

  • Traded Value (₹ in Lakhs)

    8,715.85

  • 52 Week High

    1,231.00

  • 52 Week Low

    768.65

  • Price BSE

    946.0

  • Price NSE

    949.00

  • Market Capital( in Cr.)

    8,715.85

  • P/C Ratio

    52.90

  • P/E Ratio

    118.50

  • Price Vs.BV

    8.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,180.14 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,180.14 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57
Other Income 123.06 2,873.24 127.54 84.07 123.49 117.09
Stock Adjustments -11.02 27.20 -14.87 -21.04 -114.26 117.53
Total Income 2,292.18 5,039.86 1,978.79 1,917.53 1,988.23 2,092.19
EXPENDITURE :            
Raw Materials 1,098.99 1,110.74 954.29 1,044.57 987.26 1,106.41
Power and Fuel Cost 32.96 36.00 47.90 45.54 43.76 45.82
Employee Cost 381.60 377.59 348.92 267.01 272.09 272.72
Other Manufacturing Expenses 155.84 132.85 143.04 130.03 151.87 134.86
Selling and Administration Expenses 270.16 246.18 192.14 182.64 260.83 171.51
Miscellaneous Expenses -55.49 0.85 19.83 80.19 72.31 84.56
Employee Benefit Expenses 381.60 377.59 348.92 267.01 272.09 272.72
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,884.07 1,904.21 1,706.11 1,749.98 1,788.12 1,815.87
Operating Profit 408.11 3,135.66 272.68 167.54 200.11 276.32
Interest 113.77 145.91 139.38 138.68 74.24 65.34
Gross Profit 294.34 2,989.75 133.30 28.86 125.87 210.98
Depreciation 91.24 84.61 87.41 93.62 104.37 99.34
Profit Before Tax 203.10 2,905.14 45.89 -64.76 21.50 111.64
Current Tax 17.00 -1.46 -0.12 -49.84 -169.66 33.65
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.47 20.39 1.46 -19.60 10.98 -0.26
Reported Net Profit 183.64 2,886.21 44.55 4.68 180.19 78.24
Extraordinary Items 110.08 -0.12 -5.53 -16.32 4.23 3.26
Adjusted Net Profit 73.56 2,886.33 50.08 21.00 175.96 74.98
Adjustment below Net Profit 0.00 -2,827.06 -57.19 0.00 0.00 0.00
P & L Balance brought forward 755.55 719.38 745.57 740.89 583.13 522.80
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 36.87 22.99 13.55 0.00 22.43 17.91
P & L Balance carried down 902.32 755.55 719.38 745.57 740.89 583.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 40.00 25.00 15.00 0.00 25.00
Dividend Per Share(Rs) 5.00 4.00 2.50 1.50 0.00 2.50
Earnings Per Share-Unit Curr 19.92 313.16 4.85 0.52 20.07 8.72
Earnings Per Share(Adj)-Unit Curr 19.92 313.16 2.13 0.23 8.79 3.82
Book Value 356.23 346.42 383.84 380.71 379.36 362.18
Book Value(Adj)-Unit Curr 356.23 346.42 168.20 166.83 166.24 158.71

Shareholding Pattern

  • Promoter Group

    27.91%

  • Public Share Holding

    72.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 734 0.00 734 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,908,899 4.24 3,908,899 10
Partnership Firms-Indian (Promoter & Group) 21,309,635 23.12 21,309,635 2
Persons Acting in Concert 0 0.00 0 0
Trusts 510,000 0.55 510,000 2
Others 0 0.00 0 0
Sub Total 25,729,268 27.91 25,729,268 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,125 0.01 8,125 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,025 0.01 7,999 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,171,427 28.39 26,171,427 229
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,595,627 4.99 4,595,627 4
Mutual Funds / UTI 8,043,509 8.73 8,043,509 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,553,596 1.69 1,553,596 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40,381,309 43.81 40,380,283 262
2] Non Institution
Bodies Corporate 3,498,894 3.80 3,497,776 863
Clearing Members 689 0.00 689 3
Directors of their Relatives 110,946 0.12 110,946 9
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,941,186 2.11 1,939,879 1,173
Foreign Non Institution Other 21,000 0.02 21,000 1
Hindu Undivided Families 1,159,881 1.26 1,159,881 1,807
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,941,660 7.53 6,941,660 89
Individuals holding nominal share capital up to Rs. 1 lakh 11,882,223 12.89 11,826,346 89,337
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,065 0.00 1,065 6
Others 504,593 0.55 504,593 1,291
Sub Total 26,062,137 28.28 26,003,835 94,579
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,172,714 100.00 92,113,386 94,856

Company Background

Strides Pharma Science LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Strides Pharma Science Ltd
  • BSE Code : 16996.0
  • ISIN : INE939A01011

  • Incorporation Year

    1990

  • Registered Office

    No 201 Devavrata Sector 17
    Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924/27893199

  • FAX

    91-22-27892942

  • Chairman

    Arun Kumar

  • Managing Director

  • Company Secretary

    Manjula Ramamurthy

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Strides Pharma Science Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Strides Pharma 945.60 2,303.20 2,180.14 35.83 4.81
Abbott India 26,587.05 7,217.19 6,929.05 34.99 43.78
Astrazeneca Phar 7,649.85 2,304.07 2,275.58 112.75 27.86
Glaxosmi. Pharma 2,883.20 3,932.76 3,790.20 46.06 58.17
Novartis India 1,594.05 398.23 356.27 40.25 16.64
Cipla 1,431.85 20,102.60 18,979.95 37.63 13.88
Bliss GVS Pharma 545.45 773.53 729.81 50.65 12.51
Amrutanjan Healt 488.65 469.50 451.82 26.17 21.89
Fermenta Biotec. 454.50 474.15 450.25 21.22 18.77
Guj. Themis Bio. 372.35 152.47 150.80 83.30 27.21
Ambalal Sarabhai 47.70 19.52 3.94 88.33 6.77